Vident Investment Advisory’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,349
Closed -$209K 1314
2023
Q1
$209K Sell
2,349
-1,385
-37% -$121K 0.01% 1089
2022
Q4
$320K Sell
3,734
-20,649
-85% -$1.75M 0.01% 862
2022
Q3
$1.68M Sell
24,383
-3,093
-11% -$277K 0.05% 424
2022
Q2
$2.67M Buy
27,476
+1,838
+7% +$187K 0.08% 290
2022
Q1
$2.88M Buy
25,638
+18,381
+253% +$1.96M 0.08% 292
2021
Q4
$980K Buy
7,257
+894
+14% +$124K 0.03% 715
2021
Q3
$898K Buy
6,363
+4,493
+240% +$604K 0.03% 714
2021
Q2
$240K Buy
+1,870
New +$220K 0.01% 993

Other funds holding QDEL

Vident Investment Advisory's QDEL Position: Q2 2023 in Review

Vident Investment Advisory sold out of QuidelOrtho (QDEL) in Q2 2023, closing a stake of 2,349 shares — an estimated $209K sold.

Vident Investment Advisory first reported a position in QDEL in Q2 2021 and held it in 8 quarters. The position peaked at $2.88M in Q1 2022. 313 funds tracked by Wall St. Rank hold QDEL as of Q2 2023.

  • Vident Investment Advisory reported no remaining QuidelOrtho position as of Q2 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 2,349 QuidelOrtho shares in Q2 2023, an estimated $209K.
  • Vident Investment Advisory first reported a position in QuidelOrtho in Q2 2021 and held it in 8 quarters.
  • Vident Investment Advisory's QuidelOrtho position peaked at $2.88M in Q1 2022.
  • 313 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2023.

Based on Vident Investment Advisory's 13F filing for Q2 2023, filed 11 Aug 2023.